ArticleInternational journal of general medicine2025
Ultrasonic Parameters as Biomarkers for Tumor Staging and Aggressiveness in Breast Cancer: Correlation with GP73 and miR-27a.
Article in International journal of general medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To investigate correlations between CEUS parameters and serum GP73/miR-27a in breast cancer. Methods: In the study, 117 highly suspected breast cancer diagnosed and treated in our hospital during March 2022 to April 2024 were included. Meanwhile, pathologic examination was used as the gold standard for diagnosis in this study. The 117 subjects were divided into breast cancer group (69 cases) and non-breast cancer group (48 cases). Both groups underwent contrast-enhanced ultrasound (CEUS), and the parameters of peak intensity (PI), time to peak (TTP), wash-inslope (WIS), gradient (Grad) were recorded. The levels of GP73 and miR-27 in serum of both groups were examined. The relationship between ultrasonography parameters and serum GP73 and miR-27a expression levels was evaluated by correlation analysis. Results: CEUS parameters (PI, WIS, Grad) in cancer patients were significantly higher than benign group (P<0.05), while TTP was lower. GP73 and miR-27a levels were elevated in cancer patients (P<0.05), with stage III-IV showing higher values than stage I-II (P<0.05). GP73 correlated positively with Grad (r=0.330, P=0.006), while miR-27a correlated with WIS (r=0.311, P=0.009) and Grad (r=0.424, P<0.001). ROC analysis revealed AUCs of 0.771-0.776 for individual parameters and 0.945 for combined markers. Conclusion: CEUS parameters and serum GP73/miR-27a levels correlate with breast cancer severity, demonstrating synergistic diagnostic value (AUC=0.945), supporting their combined use for early detection and progression assessment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.